{"id":302816,"date":"2025-07-30T02:54:09","date_gmt":"2025-07-30T02:54:09","guid":{"rendered":"https:\/\/www.europesays.com\/uk\/302816\/"},"modified":"2025-07-30T02:54:09","modified_gmt":"2025-07-30T02:54:09","slug":"b-c-eyes-drug-panel-changes-after-charleigh-pollock-controversy-ctv-news","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/uk\/302816\/","title":{"rendered":"B.C. eyes drug panel changes after Charleigh Pollock controversy &#8211; CTV News"},"content":{"rendered":"<ol>\n<li><a href=\"https:\/\/news.google.com\/rss\/articles\/CBMipwFBVV95cUxQTTZ3eGtOaHNLcXhuVmZneF9yVkZoQjBTajUycnNfVVY4SnF1RjItTEV2Sl92OEk3WFhTOFU1bDQ5aGFyT01wZkhaNnlXS0lCbGJCLXMycGJaNng4REVhLXpsbTJZTHBHYlJ3R0k1UnhFMnNvdVZMSTZIRTc3LVJWaTJUaWRVUVpHdWsxeVpDTmNTZnVDUDM1U3FNUHpncjUzTFVwVkQyMA?oc=5\" target=\"_blank\" rel=\"noopener\">B.C. eyes drug panel changes after Charleigh Pollock controversy<\/a>&nbsp;&nbsp;CTV News<\/li>\n<li><a href=\"https:\/\/news.google.com\/rss\/articles\/CBMiugFBVV95cUxPV2FxWXJMblNYYU1Vc2tPcU5rUVg1TlNhNWxtTFBWR3oyaWlkZ1B6ZklQdnBCU09PbzFPNmJLSzNXUktuTHlhS3k2RnNQRFI4UkpVVDNyb2tyS09OaEF1MmNLb2p0X2J4Z1RTbm4tckhWbzZ0UWg1WndxbHN2dnJBV2JvVy1QMGdTUDZzRlllNHhyeHExamo2TFU5UGUtV1RjdWd3OGVXSlRpTEd5YWlSbV9KckVZLUctMkE?oc=5\" target=\"_blank\" rel=\"noopener\">Opinion: Is denying a drug to a terminally ill 10-year-old cruel \u2013 or is it good governance?<\/a>&nbsp;&nbsp;The Globe and Mail<\/li>\n<li><a href=\"https:\/\/news.google.com\/rss\/articles\/CBMirAFBVV95cUxNT1NhekdsMUlnd0o5WUI0NENOQ0NITEVIOS1fRTh1ZGdSSUxOQjJjTkRHVjk2eTJKQmhsVEhiemlFaDRNVENudllJS3pyVGVxc1Q5cWVNSER4MjJsS2hsSlRiaDY2eEFvdjQ0ak5YREFRTlFGVTdNU0VSa0lnNnF1VlpjMFdNb1d5MjVIV1NyNmRXTHRGT0VRako0OHpEbnBoQ1ZLeHp6RjlSUnV4?oc=5\" target=\"_blank\" rel=\"noopener\">Opinion: The monumental challenge of expensive drugs for rare diseases<\/a>&nbsp;&nbsp;Vancouver Sun<\/li>\n<li><a href=\"https:\/\/news.google.com\/rss\/articles\/CBMikgFBVV95cUxNaVhBenQ5WTRZRWozMEhWQnhWVTd0ai1uNV9kaTduX3hhM0cyZjVSYjZaQ0E4RGZBeVJjZWZVbVNUTk9GVVZrYnI5OGFmNlVfYVd0cWV0ZTNZYlhJZE9jeDYwNFlTQVpLU2NRSktzcEM5Zy1yVC0yN3FRMFJxR2lKN0IzcE1YTkdfNVVBNzc4d0gtdw?oc=5\" target=\"_blank\" rel=\"noopener\">Letters to the Editor (6): Friday, July 25, 2025<\/a>&nbsp;&nbsp;Penticton Herald<\/li>\n<li><a href=\"https:\/\/news.google.com\/rss\/articles\/CBMiwwFBVV95cUxPejloUjM2M0g2aFN4LWEtUFRlVHFtTi16OG1Pcld5MHVneDUyVDU3UnROOWV4MVRkYmxYSERWaUxvMjlnSHdfejBLbm9LVGctTlNUMGxfX21KV1JSOFc1RVhENnRnQVpRN1dKbUpaRG1MX3EySTZTRU9VUl9WZTVuNTZrZ2loSWxDeGlyZWwzaGgtbkJXV3ozcmdFTTV5ckhBRFg5ZnFMSnpWdlZsWGcwNVJ2ZG9IN3hTRUJoVG1Ueko0bXc?oc=5\" target=\"_blank\" rel=\"noopener\">Letter: Reinstating medical treatment funding for Charleigh the right thing<\/a>&nbsp;&nbsp;Ladysmith Chemainus Chronicle<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"B.C. eyes drug panel changes after Charleigh Pollock controversy&nbsp;&nbsp;CTV News Opinion: Is denying a drug to a terminally&hellip;\n","protected":false},"author":2,"featured_media":302817,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4315],"tags":[105,4326,16,15],"class_list":{"0":"post-302816","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-medication","8":"tag-health","9":"tag-medication","10":"tag-uk","11":"tag-united-kingdom"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@uk\/114939931122866986","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/302816","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/comments?post=302816"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/302816\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media\/302817"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media?parent=302816"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/categories?post=302816"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/tags?post=302816"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}